Skip to main content
. 2020 Jun 17;10:9832. doi: 10.1038/s41598-020-66785-1

Figure 5.

Figure 5

Immunophenotyping of tumor cells within fabricated constructs and clinical sample. Samples from constructs cultured in vitro, constructs implanted in vivo, and clinical CRC biopsies of varying grade were immune-stained for markers related to EMT and oncogenesis, as indicated. Staining results were analyzed using Visiopharm and graphed as the proportion of cancer cells with: (a) nuclear localization of Ki67; (b) with fully intact, membrane localized E-Cadherin expression; (c) with N-Cadherin expression; (d) with nuclear localization of β-Catenin. (e) Ratio of total area corresponding to positive FAK expression in tumor spheroid and clinical CRC biopsies of varying grade. Graphs represent mean + s.e.m. of three regions of interest from each sample of experiments performed in triplicate.